A Novel Role For Nanog As An Early Cancer Risk Marker In Patients With Laryngeal Precancerous Lesions
Juan P. Rodrigo(Universidad de Oviedo), Juana García-Pedrero(Universidad de Oviedo)
Cited by 42
Related Papers
Impact of PI3K/AKT/mTOR pathway activation on the prognosis of patients with head and neck squamous cell carcinomas
|Oncotarget|2016|77
The Emerging Role of NANOG as an Early Cancer Risk Biomarker in Patients with Oral Potentially Malignant Disorders
|Journal of Clinical Medicine|2019|41
Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor–Positive Breast Cancer
|Cancer Research|2023|15
Lectin-like Transcript-1 (LLT1) Expression in Oral Squamous Cell Carcinomas: Prognostic Significance and Relationship with the Tumor Immune Microenvironment
|International Journal of Molecular Sciences|2024|3